A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.
Clinical trial NCT06272812 · RECRUITING
Trial details
- NCT number
- NCT06272812
- Sponsor
- International AIDS Vaccine Initiative
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2028-03-31
- Enrollment
- 5500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.